卵巢癌组织Hippo-Yes相关蛋白表达与临床病理参数及增殖凋亡相关性研究

发布时间：2019-08-01 14:12

【摘要】：目的探讨卵巢癌组织中Hippo-Yes相关蛋白(Yes-associated protein,YAP)的表达与临床病理参数的关系,及其对卵巢癌细胞增殖和凋亡的影响。方法免疫组化染色技术检测湖南省肿瘤医院病理科2010-01-01-2013-12-31保存的68例卵巢癌及38例良性卵巢组织中YAP蛋白表达,分析YAP表达与卵巢癌临床病理参数的相关性;逆转录病毒介导的YAP shRNA干扰人卵巢癌EFO-21细胞中YAP表达,蛋白质印迹法检测干扰效率,5-溴脱氧尿嘧啶核苷(5-Bromo-2-deoxy Uridine,BrdU)细胞增殖分析和流式细胞术检测肿瘤细胞增殖和凋亡变化。结果卵巢癌组织YAP蛋白阳性表达率为61.8%(42/68),良性卵巢组织为10.5%(4/38),差异有统计学意义,χ2=26.054,P0.001。卵巢癌组织中YAP蛋白阳性表达率在高临床分期(χ2=8.600,P=0.003)和高病理分级(χ2=5.688,P=0.017)中显著升高。YAP shRNA显著降低卵巢癌EFO-21细胞中YAP蛋白表达,对照组YAP蛋白表达为0.96±0.16,实验组为0.14±0.04,P0.001。YAP shRNA导致肿瘤细胞增殖能力显著减弱,对照组细胞增殖水平为121.00±3.19,实验组为55.83±3.56,P0.001。YAP shRNA并诱导细胞凋亡,对照组凋亡率为(8.75±0.15)%,实验组为(32.75±4.76)%,P0.001。结论 YAP蛋白在卵巢癌组织中表达异常升高并核内蓄积,其阳性表达与高病理分级和高临床分期显著有关,干扰YAP表达导致肿瘤细胞增殖减弱和凋亡增加,提示YAP通过促进肿瘤细胞生长发挥促癌作用,其可能成为卵巢癌靶向治疗的潜在靶点。
[Abstract]:Objective to investigate the relationship between the expression of Hippo-Yes associated protein (Yes-associated protein,YAP) and clinicopathological parameters in ovarian cancer and its effect on proliferation and apoptosis of ovarian cancer cells. Methods Immunohistochemical staining was used to detect the expression of YAP protein in 68 cases of ovarian cancer and 38 cases of benign ovarian tissue preserved in the Department of Pathology, Hunan Cancer Hospital. The correlation between the expression of YAP and the clinicopathological parameters of ovarian cancer was analyzed. Retrovirus-mediated YAP shRNA interfered with the expression of YAP in human ovarian cancer EFO-21 cells. Western imprinting was used to detect the interference efficiency. 5-bromodeoxyuridine (5-Bromo-2-deoxy Uridine,BrdU) cell proliferation analysis and flow cytometry were used to detect the proliferation and apoptosis of human ovarian cancer cells. Results the positive expression rate of YAP protein was 61.8% (42 鈮，

本文编号：2521802